TrialAntimicrobial agents and chemotherapy2023

A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19.

Yeon-Sook Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.